InvestorsHub Logo
Followers 2
Posts 2139
Boards Moderated 0
Alias Born 12/19/2016

Re: mcsharkey post# 54273

Thursday, 12/06/2018 7:34:43 PM

Thursday, December 06, 2018 7:34:43 PM

Post# of 58912
Well, gene therapies are the soup du jour lately.
It’s on the news daily.
So, maybe Hayward is appealing to a whole new class of investor.

The old, security oriented group is burned out. I guess it’s goodbye to pharma, cotton etc. and hello to linear pcr based dna??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News